132 related articles for article (PubMed ID: 22420963)
1. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.
Hoogsteen IJ; Marres HA; van den Hoogen FJ; Rijken PF; Lok J; Bussink J; Kaanders JH
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):807-14. PubMed ID: 22420963
[TBL] [Abstract][Full Text] [Related]
2. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
[TBL] [Abstract][Full Text] [Related]
4. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
5. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
[TBL] [Abstract][Full Text] [Related]
6. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
Raleigh JA; Chou SC; Calkins-Adams DP; Ballenger CA; Novotny DB; Varia MA
Clin Cancer Res; 2000 Mar; 6(3):855-62. PubMed ID: 10741707
[TBL] [Abstract][Full Text] [Related]
7. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
8. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome: in regard to Evans et al. (Int J Radiat Oncol Biol Phys 2007;69:1024-1031).
Bussink J; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1616. PubMed ID: 18374238
[No Abstract] [Full Text] [Related]
9. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
[TBL] [Abstract][Full Text] [Related]
11. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
12. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.
Raleigh JA; Calkins-Adams DP; Rinker LH; Ballenger CA; Weissler MC; Fowler WC; Novotny DB; Varia MA
Cancer Res; 1998 Sep; 58(17):3765-8. PubMed ID: 9731480
[TBL] [Abstract][Full Text] [Related]
17. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
Wijffels KI; Kaanders JH; Rijken PF; Bussink J; van den Hoogen FJ; Marres HA; de Wilde PC; Raleigh JA; van der Kogel AJ
Br J Cancer; 2000 Sep; 83(5):674-83. PubMed ID: 10944611
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
